MicroRNAs for Diabetes Management: From Natural Bioactive Compounds to Nucleotide Networks
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1867005262913601537 |
|---|---|
| author | Junren Chen Maozhu Luo Siqi Qin Cheng Peng Dan Li |
| author_facet | Junren Chen Maozhu Luo Siqi Qin Cheng Peng Dan Li Junren Chen Maozhu Luo Siqi Qin Cheng Peng Dan Li |
| collection | Wiley Open Access |
| contents | MicroRNAs for Diabetes Management: From Natural Bioactive Compounds to Nucleotide Networks Junren Chen Maozhu Luo Siqi Qin Cheng Peng Dan Li Phytotherapy Research ABSTRACTMicroRNAs (miRNAs) have emerged as critical regulators in the pathogenesis of diabetes mellitus (DM) and its associated complications via orchestrating key cellular processes. Natural bioactive components such as flavonoids, polysaccharides, saponins, alkaloids, terpenoids, as well as anthraquinones derived from berries, herbs, vegetables, and fishes have been extensively demonstrated to treat or prevent DM and related complications through targeting miRNAs‐mediated signaling pathways. Mechanistically, these compounds treat/prevent DM and its complications principally by modulating processes including glucose homeostasis, inflammatory response, oxidative stress, apoptosis, and autophagy, neovascularization, and fibrosis. This paper reviews the roles of miRNAs in DM and relevant complications and focuses on the potential molecular mechanisms of natural bioactive compounds in the treatment of DM and its complications by targeting miRNAs, with the aim of facilitating the development of miRNA‐targeted edible natural products as functional foods as well as their clinical application in the treatment of DM and related complications. 10.1002/ptr.70084 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/ptr.70084 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_ptr_70084 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2025 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | MicroRNAs for Diabetes Management: From Natural Bioactive Compounds to Nucleotide Networks Junren Chen Maozhu Luo Siqi Qin Cheng Peng Dan Li Phytotherapy Research MicroRNAs for Diabetes Management: From Natural Bioactive Compounds to Nucleotide Networks Junren Chen Maozhu Luo Siqi Qin Cheng Peng Dan Li Phytotherapy Research ABSTRACTMicroRNAs (miRNAs) have emerged as critical regulators in the pathogenesis of diabetes mellitus (DM) and its associated complications via orchestrating key cellular processes. Natural bioactive components such as flavonoids, polysaccharides, saponins, alkaloids, terpenoids, as well as anthraquinones derived from berries, herbs, vegetables, and fishes have been extensively demonstrated to treat or prevent DM and related complications through targeting miRNAs‐mediated signaling pathways. Mechanistically, these compounds treat/prevent DM and its complications principally by modulating processes including glucose homeostasis, inflammatory response, oxidative stress, apoptosis, and autophagy, neovascularization, and fibrosis. This paper reviews the roles of miRNAs in DM and relevant complications and focuses on the potential molecular mechanisms of natural bioactive compounds in the treatment of DM and its complications by targeting miRNAs, with the aim of facilitating the development of miRNA‐targeted edible natural products as functional foods as well as their clinical application in the treatment of DM and related complications. 10.1002/ptr.70084 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | MicroRNAs for Diabetes Management: From Natural Bioactive Compounds to Nucleotide Networks |
| topic | Phytotherapy Research |
| url | https://onlinelibrary.wiley.com/doi/10.1002/ptr.70084 |